Clinical Conversations: Acute Stroke Treatments and Secondary Stroke Prevention | Part Two

Prof Bruce Campbell

writer

Prof Bruce Campbell

Neurologist; Head, Neurology and Stroke, Royal Melbourne Hospital; Professor of Neurology, Department of Medicine, Royal Melbourne Hospital

 

Never before has it been so important to educate our patients about the importance of calling triple zero promptly if they have symptoms that could be a stroke as this will result in far better outcomes. The F.A.S.T. test should be displayed in all medical waiting rooms and hospitals. Professor Bruce Campbell explains the newest technology and medications used in acute stroke and secondary stroke prevention. This is part two of a two-part article.

This is part two of this series. Read Part 1 >>

Practice points

• If you get a focal deficit that is sudden onset (the average duration is about ten minutes,), the patient needs exactly the same workup as a stroke.
• Look at the carotid arteries, look for atrial fibrillation, start anti-platelet therapy really quickly. Brain imaging is very worthwhile, such as a CT scan to exclude a bleed; an MRI should be normal in a TIA.
• GPs need to ensure patients have adequate and appropriate secondary stroke prevention therapy.
• Look hard for atrial fibrillation, as anti-platelet therapies will not prevent stroke recurrence if the emboli are atrial in origin. It is definitely worth feeling the pulse every time you see the patient as a single Holter monitor has pretty low sensitivity.
• If you have a patient who’s had a normal Holter monitor, but you are suspicious that they really have had an embolic event, you can certainly take advice from your local stroke team.
• Dual anti-platelet therapy (aspirin and clopidogrel) is used for ischaemic stroke/TIA for three weeks and then clopidogrel is continued.
• The evidence is that we need to reduce the LDL to a target of less than 1.8 mmol/L.
• Reduce the blood pressure as low as you can get it without making the patient feel horrible, certainly a systolic consistently less than 140 mmHg.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

Further your CPD learning

Based on this educational activity, complete these learning modules to gain additional CPD.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Marie-Claire Seeley

Dr Marie-Claire Seeley

Postural Orthostatic Tachycardia Syndrome in Women

Dr Charlotte Hespe & Dr Ramy Bishay

Dr Charlotte Hespe & Dr Ramy Bishay

Panel Discussion on The Role of GLP-1 in the Management of CKD in T2D

Dr Anthony Chitti

Dr Anthony Chitti

Big Heads & Small Heads

Dr Sam Mehr

Dr Sam Mehr

Peanut Allergy

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Prof Bruce Campbell

writer

Prof Bruce Campbell

Neurologist; Head, Neurology and Stroke, Royal Melbourne Hospital; Professor of Neurology, Department of Medicine, Royal Melbourne Hospital

Test your knowledge

Recent articles

Latest GP poll

What impact do you think publishing fee data will have on the cost to patients to see a GP?

Increase

0%

No change

0%

Decrease

0%

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

Panel Discussion on The Role of GLP-1 in the Management of CKD in T2D

Tuesday 17th March, 7pm - 9pm AEDT

Speakers

Dr Charlotte Hespe & Dr Ramy Bishay

General Practitioner & Endocrinologist

Join Dr Charlotte Hespe and Dr Ramy Bishay for this expert panel webcast presentation, where they will discuss the role of GLP-1 in the management of CKD in T2D.